Elucidation of the Mechanisms of Human cathelicidin-derived Antimicrobial Peptides (LL-37 and its Truncated LL-31) Against Burkholderia Pseudomallei

被引:0
|
作者
Onanong Phophetleb
Wonn Shweyi Thet Tun
Sompong Klaynongsruang
Sakda Daduang
Suwimol Taweechaisupapong
Rina Patramanon
机构
[1] Khon Kaen University,Department of Biochemistry, Faculty of Science
[2] Khon Kaen University,Protein and Proteomics Research Group
[3] Khon Kaen University,Department of Chemistry, Faculty of Science
[4] Khon Kaen University,Faculty of Pharmaceutical Sciences
[5] Khon Kaen University,Melioidosis Research Center
[6] Khon Kaen University,Biofilm research group, Faculty of Dentistry
关键词
antimicrobial peptides; LL-37 and LL-31; Melioidosis;
D O I
暂无
中图分类号
学科分类号
摘要
Melioidosis is an endemic disease caused by Burkholderia pseudomallei found in tropical areas. The bacterium is intrinsically resistant to conventional antibiotics, making treatment difficult. Cathelicidin-derived peptides LL-37, and its truncated LL-31 played a crucial role in innate immune defense against infected microorganisms. LL-31 showed superior killing activity than LL-37 in reducing bacteria viability, combination with antibiotic ceftazidime (CAZ), outer and inner membrane permeabilization, membrane depolarization, and affinity binding to lipopolysaccharide (LPS) of B. pseudomallei. Both peptides had similar content of alpha-helical structure. This study provided insights into the molecular mechanisms of LL-37 and its truncated form, LL-31. By utilizing the knowledge gained from this study, researchers may be able to improve treatment options and help combat the spread of antibiotic-resistant bacteria.
引用
收藏
相关论文
共 50 条
  • [31] Identification of Peptides Derived from the Human Antimicrobial Peptide LL-37 Active against Biofilms Formed by Pseudomonas aeruginosa Using a Library of Truncated Fragments
    Nagant, C.
    Pitts, B.
    Nazmi, K.
    Vandenbranden, M.
    Bolscher, J. G.
    Stewart, P. S.
    Dehaye, J. -P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5698 - 5708
  • [32] The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
    Currie, Silke M.
    Findlay, Emily Gwyer
    McHugh, Brian J.
    Mackellar, Annie
    Man, Tian
    Macmillan, Derek
    Wang, Hongwei
    Fitch, Paul M.
    Schwarze, Juergen
    Davidson, Donald J.
    PLOS ONE, 2013, 8 (08):
  • [33] Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13
    Bucki, Robert
    Namiot, Dorota B.
    Namiot, Zbigniew
    Savage, Paul B.
    Janmey, Paul A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (02) : 329 - 335
  • [34] Dermcidin-Derived Peptides Show a Different Mode of Action than the Cathelicidin LL-37 against Staphylococcus aureus
    Senyuerek, Ilknur
    Paulmann, Maren
    Sinnberg, Tobias
    Kalbacher, Hubert
    Deeg, Martin
    Gutsmann, Thomas
    Hermes, Marina
    Kohler, Thomas
    Goetz, Fritz
    Wolz, Christiane
    Peschel, Andreas
    Schittek, Birgit
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (06) : 2499 - 2509
  • [35] Immunomodulatory Functions of the Human Cathelicidin LL-37 (aa 13-31)-Derived Peptides are Associated with Predicted α-Helical Propensity and Hydrophobic Index
    Hemshekhar, Mahadevappa
    Faiyaz, Sana
    Choi, Ka-Yee Grace
    Krokhin, Oleg, V
    Mookherjee, Neeloffer
    BIOMOLECULES, 2019, 9 (09)
  • [36] Role of uropathogenic Escherichia coli OmpT in the resistance against human cathelicidin LL-37
    Brannon, John R.
    Thomassin, Jenny-Lee
    Desloges, Isabelle
    Gruenheid, Samantha
    Le Moual, Herve
    FEMS MICROBIOLOGY LETTERS, 2013, 345 (01) : 64 - 71
  • [37] The Human Cathelicidin Antimicrobial Peptide LL-37 Promotes the Growth of the Pulmonary Pathogen Aspergillus fumigatus
    Sheehan, Gerard
    Bergsson, Gudmundur
    McElvaney, Noel G.
    Reeves, Emer P.
    Kavanagh, Kevin
    INFECTION AND IMMUNITY, 2018, 86 (07)
  • [38] Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence
    Zaiou, M
    Nizet, V
    Gallo, RL
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (05) : 810 - 816
  • [39] Carbon Nanoparticles Inhibit the Antimicrobial Activities of the Human Cathelicidin LL-37 through Structural Alteration
    Findlay, Fern
    Pohl, Jan
    Svoboda, Pavel
    Shakamuri, Priyanka
    McLean, Kevin
    Inglis, Neil F.
    Proudfoot, Lorna
    Barlow, Peter G.
    JOURNAL OF IMMUNOLOGY, 2017, 199 (07): : 2483 - 2490
  • [40] Expression of a human cathelicidin antimicrobial peptide, LL-37, in amniotic fluid with neonatal or maternal infection
    Yoshio, H
    Yamada, M
    Yoshida, M
    Takeuchi, A
    Fujii, S
    Kunii, Y
    Kageyama, M
    Yokoi, Y
    Yamauchi, Y
    Agerberth, B
    PEDIATRIC RESEARCH, 2005, 58 (02) : 427 - 427